Home > Boards > US Listed > Medical - Drugs > Evofem (EVFM)

This stock is so volatile. When volume comes

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
snidely Member Profile
 
Followed By 11
Posts 1,803
Boards Moderated 0
Alias Born 10/24/06
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/11/2019 4:30:22 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 10/11/2019 4:08:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 11:56:31 AM
Evofem Biosciences to Present at Cantor Global Healthcare Conference on October 4, 2019 PR Newswire (US) - 9/25/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2019 9:08:45 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2019 6:38:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2019 6:37:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2019 6:37:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2019 6:37:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2019 6:37:03 PM
Evofem Biosciences Completes Phase 2b 'AMPREVENCE' Trial of Amphora for Prevention of Chlamydia and Gonorrhea in Women PR Newswire (US) - 8/26/2019 6:00:00 AM
Evofem Biosciences to Present at Upcoming Healthcare Conferences PR Newswire (US) - 8/22/2019 9:30:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/12/2019 5:19:40 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 6:14:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2019 4:12:58 PM
Evofem Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire (US) - 8/5/2019 4:10:00 PM
Evofem Biosciences Reports Additional Data from Phase 3 'AMPOWER' Study of Amphora® for Hormone-Free Birth Control PR Newswire (US) - 8/5/2019 4:05:00 PM
Evofem Biosciences to Report Second Quarter 2019 Results and Provide Corporate Update on August 6, 2019 PR Newswire (US) - 7/30/2019 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/10/2019 7:07:04 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/3/2019 6:12:47 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 7/2/2019 5:13:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2019 2:43:29 PM
Evofem Biosciences Added to Russell 3000® Index PR Newswire (US) - 7/1/2019 9:31:00 AM
Withdrawal of Registration Statement (rw) Edgar (US Regulatory) - 6/24/2019 4:12:20 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 6/24/2019 4:10:17 PM
snidely   Thursday, 03/01/18 11:50:30 AM
Re: None
Post # of 146 
This stock is so volatile. When volume comes in its a wrap

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist